TY - JOUR
T1 - Can network analysis improve pattern recognition among adverse events following immunization reported to VAERS
AU - Ball, R.
AU - Botsis, T.
PY - 2011/8
Y1 - 2011/8
N2 - Current methods of statistical data mining are limited in their ability to facilitate the identification of patterns of potential clinical interest from spontaneous reporting systems of medical product adverse events (AEs). Network analysis (NA) allows for simultaneous representation of complex connections among the key elements of such a system. The Vaccine Adverse Event Reporting System (VAERS) can be represented as a network of 6,428 nodes (74 vaccines and 6,354 AEs) with more than 1.4 million interlinkages. VAERS has the characteristics of a scale-free network, with certain vaccines and AEs acting as hubs in the network. Known safety signals were visualized using NA methods, including hub identification. NA offers a complementary approach to current statistical data-mining techniques for visualizing multidimensional patterns, providing a structural framework for evaluating AE data.
AB - Current methods of statistical data mining are limited in their ability to facilitate the identification of patterns of potential clinical interest from spontaneous reporting systems of medical product adverse events (AEs). Network analysis (NA) allows for simultaneous representation of complex connections among the key elements of such a system. The Vaccine Adverse Event Reporting System (VAERS) can be represented as a network of 6,428 nodes (74 vaccines and 6,354 AEs) with more than 1.4 million interlinkages. VAERS has the characteristics of a scale-free network, with certain vaccines and AEs acting as hubs in the network. Known safety signals were visualized using NA methods, including hub identification. NA offers a complementary approach to current statistical data-mining techniques for visualizing multidimensional patterns, providing a structural framework for evaluating AE data.
UR - http://www.scopus.com/inward/record.url?scp=79960601887&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960601887&partnerID=8YFLogxK
U2 - 10.1038/clpt.2011.119
DO - 10.1038/clpt.2011.119
M3 - Article
C2 - 21677640
AN - SCOPUS:79960601887
SN - 0009-9236
VL - 90
SP - 271
EP - 278
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
IS - 2
ER -